Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology
Biocitech Park, Romainville, France (ots/PRNewswire) - Cellectis SA (NYSE: ALCLS), a world leader in rational genome engineering, has announced today that it filed a patent infringement lawsuit against Precision BioSciences, Inc. in the United States District Court for the Eastern District of North Carolina. ...
mehr